Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?

dc.date.accessioned	2023-03-06T07:32:33Z
dc.date.available	2023-03-06T07:32:33Z
dc.date.issued	2021
dc.identifier.citation	Turk J Gastroenterol. 2021 Feb;32(2):155-163. doi: 10.5152/tjg.2020.19569.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100363
dc.relation.isversionof	10.5152/tjg.2020.19569
dc.relation.isversionof	10.5152/tjg.2020.19569
dc.title	Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
dc.relation.journal	Turk J Gastroenterol
dc.identifier.doi	10.5152/tjg.2020.19569
dc.contributor.author	Demirtürk N
dc.contributor.author	Demirtürk N
dc.contributor.author	Aygen B
dc.contributor.author	Çelik İ
dc.contributor.author	Mıstık R
dc.contributor.author	Akhan S
dc.contributor.author	Barut Ş
dc.contributor.author	Ural O